SCHEMBL22985884

SCHEMBL22985884

COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1nc(Nc2ccccc2SC(C)C)c2c(Cl)c[nH]c2n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 16/20 0.62
▸ INSR P06213 13/20 0.62
▸ IGF1R P08069 13/20 0.62
▸ EGFR P00533 6/20 0.58
▸ MET P08581 3/20 0.58
▸ CHEK1 O14757 2/20 0.58
▸ AURKA O14965 2/20 0.58
▸ NUAK1 O60285 2/20 0.58
▸ JAK2 O60674 2/20 0.58
▸ STK10 O94804 2/20 0.58
▸ PRKD3 O94806 2/20 0.58
▸ CHEK2 O96017 2/20 0.58
▸ ABL1 P00519 2/20 0.58
▸ ERBB2 P04626 2/20 0.58
▸ LCK P06239 2/20 0.58
▸ FYN P06241 2/20 0.58
▸ FES P07332 2/20 0.58
▸ CSF1R P07333 2/20 0.58
▸ YES1 P07947 2/20 0.58
▸ LYN P07948 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18637132 0.88 ALK (0.81) ALKINSRIGF1REGFRMET
SCHEMBL18018790 0.86 ALK (0.79) ALKINSRIGF1REGFRMET
SCHEMBL22985890 0.84 FES (0.60) ALKINSRIGF1REGFRMET
SCHEMBL26270561 0.83 ALK (0.73) ALKINSRIGF1REGFRMET
SCHEMBL21099658 0.83 ALK (0.60) ALKINSRIGF1REGFRMET
SCHEMBL20367241 0.82 ALK (0.74) ALKINSRIGF1REGFRMET
SCHEMBL19921194 0.82 ALK (0.59) ALKINSRIGF1REGFRMET
SCHEMBL24327560 0.81 ALK (0.62) ALKINSRIGF1REGFRMET
SCHEMBL22985864 0.81 LRRK2 (0.66) CLK1CLK2MAP3K9LRRK2TTK
SCHEMBL21099498 0.79 ALK (0.60) ALKINSRIGF1REGFRMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778605-A2 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
EP-3778604-A1 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
Send feedback